Side effects could certainly be decreased with lower dose of quinidine in asymptomatic Brugada patients, but what about efficacy? Author reply.
Département de Cardiologie et Centre de référence des maladies cardiaques héréditaires, AP-HP, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France.
Abdeslam
A
Bouzeman
Département de Cardiologie et Centre de référence des maladies cardiaques héréditaires, AP-HP, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France Université Paris Diderot, Sorbonne Paris Cité, INSERM U698, 75013 Paris, France antoine.leenhardt@bch.aphp.fr.
Antoine
A
Leenhardt
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D053840:Brugada Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011802:Quinidine / Q000031:analogs & derivatives*; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D011802:Quinidine